Orion Pharma Limited (DSE:ORIONPHARM)

Revenue by Segment

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
Power	817.57M	-	-	-	8.22B
Power Growth	-	-	-	-	53.65%
Pharmaceuticals	3.26B	-	-	-	2.61B
Pharmaceuticals Growth	-	-	-	-	13.69%
Total	4.08B	-	-	-	10.83B
Total Growth	-	-	-	-	41.64%

Revenue by Geography

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
Bangladesh	3.07B	3.52B	2.86B	2.87B	2.42B
Bangladesh Growth	-12.93%	23.31%	-0.51%	18.53%	12.96%
Export	196.83M	142.71M	199.75M	123.84M	189.88M
Export Growth	37.92%	-28.56%	61.30%	-34.78%	23.95%
Unallocated	817.57M	6.96B	10.87B	6.67B	8.22B
Unallocated Growth	-88.25%	-36.01%	63.06%	-18.90%	53.65%
Total	4.08B	10.62B	13.93B	9.66B	10.83B
Total Growth	-61.57%	-23.74%	44.14%	-10.81%	41.64%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 15, 2026

Data Sources Report a data error